Clinical Trial Update: Methylene Blue and Microcirculation in Septic Shock [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating methylene blue for microcirculation in septic shock; status and results are not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• METHYLENE BLUE (METHYLENE BLUE)

Snippet

Sponsor: Cairo University | Conditions: Septic Shock | Phase 3 | Status: UNKNOWN